RDY FY 2012 Earnings Report — Dr. Reddy's Laboratories Limited Revenue & Financial Results | Market Cap Arena

Dr. Reddy's Laboratories LimitedRDY

FY 2012 Earnings

Reported July 17, 2012

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2012	Prior Q	FY 2011	QoQ Change	YoY Change
Revenue	$1.0B	—	$792M	—	29.5%
Op. Income	$194M	—	$134M	—	44.5%
Gross Margin	55.1%	—	53.9%	—	1.2pp
Net Margin	14.7%	—	14.8%	—	-0.0pp
EPS (Diluted)	$0.89	—	$0.69	—	29.0%
Free Cash Flow	$80M	—	-$38M	—	310.3%

Revenue Flow

Item	Amount
REVENUE	$1.0B
Cost of Revenue	$461M
GROSS PROFIT	$565M
R&D Expenses	$63M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$306M
Other Expenses	-$8M
Operating Expenses	$361M
Cost & Expenses	$821M
OPERATING INCOME	$194M
Interest Income	$4M
Interest Expense	$11M
Other Income/Expenses	$2M
INCOME BEFORE TAX	$196M
Income Tax Expense	$45M
Net Income from Continuing Ops	$151M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$151M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$151M
D&A	$55M
EBIT	$207M
EBITDA	$216M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.0B
Cost of Revenue	$461M
GROSS PROFIT	$565M
R&D Expenses	$63M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$306M
Other Expenses	-$8M
Operating Expenses	$361M
Cost & Expenses	$821M
OPERATING INCOME	$194M
Interest Income	$4M
Interest Expense	$11M
Other Income/Expenses	$2M
INCOME BEFORE TAX	$196M
Income Tax Expense	$45M
Net Income from Continuing Ops	$151M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$151M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$151M
D&A	$55M
EBIT	$207M
EBITDA	$216M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$151M
Depreciation & Amortization	$55M
Stock-Based Compensation	$3M
Deferred Income Tax	$45M
Other Non-Cash Items	$12M
Change in Working Capital	-$95M
OPERATING CASH FLOW	$171M
Capital Expenditure	-$91M
Acquisitions (Net)	$18M
Purchases of Investments	-$279M
Sales/Maturities of Investments	$167M
Other Investing Activities	-$13M
NET CASH FROM INVESTING	-$198M
Net Debt Issuance	$75M
Common Stock Repurchased	$0
Common Dividends Paid	-$24M
Other Financing Activities	-$12M
NET CASH FROM FINANCING	$40M
FREE CASH FLOW	$80M
Net Change in Cash	$18M

Balance Sheet

Item	Amount
Cash & Equivalents	$193M
Short-Term Investments	$0
Net Receivables	$319M
Inventory	$205M
Other Current Assets	$12M
TOTAL CURRENT ASSETS	$742M
PP&E (Net)	$353M
Goodwill	$23M
Intangible Assets	$120M
Long-Term Investments	$4M
Tax Assets	$21M
Other Non-Current Assets	$4M
TOTAL NON-CURRENT ASSETS	$525M
TOTAL ASSETS	$1.3B
Account Payables	$101M
Short-Term Debt	$168M
Deferred Revenue	$413.6K
Other Current Liabilities	$64M
TOTAL CURRENT LIABILITIES	$461M
Long-Term Debt	$170M
Deferred Revenue NC	$498.5K
Deferred Tax Liabilities	$12M
Other Non-Current Liabilities	$12M
TOTAL NON-CURRENT LIABILITIES	$197M
TOTAL LIABILITIES	$658M
Common Stock	$9M
Additional Paid-In Capital	$231M
Retained Earnings	$335M
Treasury Stock	$0
Accum. Other Comp. Income	$9M
Other Equity	$25M
TOTAL STOCKHOLDERS' EQUITY	$609M
Minority Interest	$0
TOTAL EQUITY	$609M
TOTAL LIABILITIES & EQUITY	$1.3B
Total Debt	$342M
Net Debt	$149M